+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Dry Eye Syndrome Treatment Market Size, Share & Industry Trends Analysis Report by Type, Drug, Dosage, Distribution Channel, Sales Channel, Product, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 144 Pages
  • September 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5673875
Description Jump to:
The Latin America, Middle East and Africa Dry Eye Syndrome Treatment Market would witness market growth of 9.8% CAGR during the forecast period (2022-2028).

A number of medical issues, or a side effect from some medications can all cause a decrease in tear production. Due to higher tear evaporation, environmental factors including wind and dry weather can also cause a decrease in tear volume. Dry eye signs can arise if the tears dissipate too rapidly or do not cover the cornea evenly owing to faults within any of the tear layers. As people age naturally, they can have dry eyes. The majority of adults over 65 have some dry eye problems. Because of hormonal changes brought on by menopause, oral contraceptive use, and pregnancy, women are far more likely to have dry eyes.

Also, tear production may be decreased by some drugs, including blood pressure medications, antihistamines, decongestants, and antidepressants. Dry eye symptoms are more prevalent in people with thyroid issues, diabetes, and rheumatoid arthritis. Dry eyes can also be brought on by issues with eyelid inflammation (blepharitis), infection of the eye's surface, or the outward or inward turning of the eyelids. In addition, dry eye symptoms can be exacerbated by exposure to smoke, wind, and dry environments. The eyes can dry up as a result of irregular blinking, which can happen when staring at a screen for extended periods of time, for example. DED might occur as a result of prolonged contact lens wear. It can be exacerbated by refractive eye surgery, such as LASIK, which can reduce tear production.

In a population over 40 years old in Brazil, a prior study employing the Women's Health Study (WHS) Dry Eye Symptom Survey revealed an overall prevalence of DED of 12.8%. In terms of socioeconomics and climate, the nation is diverse. The results of a previous study's sample involving thousands of participants from the five geographical areas of the country suggest that about 27 million people in Brazil as a whole are expected to have DED symptoms.

The predominance of dry eye syndrome has increased as a result of people's changing lifestyles, particularly their greater use of electronic devices like computers and TVs. Additionally, the growing elderly population is more susceptible to diseases like benign prostatic hyperplasia and high blood pressure, which increases the likelihood of getting dry eye syndrome. These factors have boosted the stronghold of the dry eye syndrome treatment market in this region.

The Brazil market dominated the LAMEA Dry Eye Syndrome Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $159.5 million by 2028. The Argentina market is registering a CAGR of 10.4% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 9.5% during (2022-2028).

Based on Type, the market is segmented into Evaporative Dry Eye Syndrome and Aqueous Deficient Dry Eye Syndrome. Based on Drug, the market is segmented into Restasis, Xiidra, Cequa, Eysuvis and Tyrvaya & Others. Based on Dosage, the market is segmented into Eye drops, Gels, Capsules & Tablets, Eye Solutions and Ointments. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Sales Channel, the market is segmented into OTC and Prescription. Based on Product, the market is segmented into Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Services, Inc.), AbbVie, Inc., Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Novartis AG, Sun Pharmaceuticals Industries Ltd., AFT Pharmaceuticals, Santen Pharmaceutical Co., Ltd., Oyster Point Pharma, Inc., OASIS Medical, Inc., and Otsuka Pharmaceutical Co., Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Evaporative Dry Eye Syndrome
  • Aqueous Deficient Dry Eye Syndrome

By Drug

  • Restasis
  • Xiidra
  • Cequa
  • Eysuvis
  • Tyrvaya & Others

By Dosage

  • Eye drops
  • Gels
  • Capsules & Tablets
  • Eye Solutions
  • Ointments

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Sales Channel

  • OTC
  • Prescription

By Product

  • Cyclosporine
  • Topical Corticosteroids
  • Artificial Tears
  • Punctal Plugs
  • Oral Omega Supplements
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • AbbVie, Inc.
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Novartis AG
  • Sun Pharmaceuticals Industries Ltd.
  • AFT Pharmaceuticals
  • Santen Pharmaceutical Co., Ltd.
  • Oyster Point Pharma, Inc.
  • OASIS Medical, Inc.
  • Otsuka Pharmaceutical Co., Ltd.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Dry Eye Syndrome Treatment Market, by Type
1.4.2 LAMEA Dry Eye Syndrome Treatment Market, by Drug
1.4.3 LAMEA Dry Eye Syndrome Treatment Market, by Dosage
1.4.4 LAMEA Dry Eye Syndrome Treatment Market, by Distribution Channel
1.4.5 LAMEA Dry Eye Syndrome Treatment Market, by Sales Channel
1.4.6 LAMEA Dry Eye Syndrome Treatment Market, by Product
1.4.7 LAMEA Dry Eye Syndrome Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Dry Eye Syndrome Treatment Market by Type
4.1 LAMEA Evaporative Dry Eye Syndrome Market by Country
4.2 LAMEA Aqueous Deficient Dry Eye Syndrome Market by Country
Chapter 5. LAMEA Dry Eye Syndrome Treatment Market by Drug
5.1 LAMEA Restasis Market by Country
5.2 LAMEA Xiidra Market by Country
5.3 LAMEA Cequa Market by Country
5.4 LAMEA Eysuvis Market by Country
5.5 LAMEA Tyrvaya & Others Market by Country
Chapter 6. LAMEA Dry Eye Syndrome Treatment Market by Dosage
6.1 LAMEA Eye drops Market by Country
6.2 LAMEA Gels Market by Country
6.3 LAMEA Capsules & Tablets Market by Country
6.4 LAMEA Eye Solutions Market by Country
6.5 LAMEA Ointments Market by Country
Chapter 7. LAMEA Dry Eye Syndrome Treatment Market by Distribution Channel
7.1 LAMEA Retail Pharmacy Market by Country
7.2 LAMEA Hospital Pharmacy Market by Country
7.3 LAMEA Online Pharmacy Market by Country
Chapter 8. LAMEA Dry Eye Syndrome Treatment Market by Sales Channel
8.1 LAMEA OTC Market by Country
8.2 LAMEA Prescription Market by Country
Chapter 9. LAMEA Dry Eye Syndrome Treatment Market by Product
9.1 LAMEA Cyclosporine Market by Country
9.2 LAMEA Topical Corticosteroids Market by Country
9.3 LAMEA Artificial Tears Market by Country
9.4 LAMEA Punctal Plugs Market by Country
9.5 LAMEA Oral Omega Supplements Market by Country
9.6 LAMEA Others Market by Country
Chapter 10. LAMEA Dry Eye Syndrome Treatment Market by Country
10.1 Brazil Dry Eye Syndrome Treatment Market
10.1.1 Brazil Dry Eye Syndrome Treatment Market by Type
10.1.2 Brazil Dry Eye Syndrome Treatment Market by Drug
10.1.3 Brazil Dry Eye Syndrome Treatment Market by Dosage
10.1.4 Brazil Dry Eye Syndrome Treatment Market by Distribution Channel
10.1.5 Brazil Dry Eye Syndrome Treatment Market by Sales Channel
10.1.6 Brazil Dry Eye Syndrome Treatment Market by Product
10.2 Argentina Dry Eye Syndrome Treatment Market
10.2.1 Argentina Dry Eye Syndrome Treatment Market by Type
10.2.2 Argentina Dry Eye Syndrome Treatment Market by Drug
10.2.3 Argentina Dry Eye Syndrome Treatment Market by Dosage
10.2.4 Argentina Dry Eye Syndrome Treatment Market by Distribution Channel
10.2.5 Argentina Dry Eye Syndrome Treatment Market by Sales Channel
10.2.6 Argentina Dry Eye Syndrome Treatment Market by Product
10.3 UAE Dry Eye Syndrome Treatment Market
10.3.1 UAE Dry Eye Syndrome Treatment Market by Type
10.3.2 UAE Dry Eye Syndrome Treatment Market by Drug
10.3.3 UAE Dry Eye Syndrome Treatment Market by Dosage
10.3.4 UAE Dry Eye Syndrome Treatment Market by Distribution Channel
10.3.5 UAE Dry Eye Syndrome Treatment Market by Sales Channel
10.3.6 UAE Dry Eye Syndrome Treatment Market by Product
10.4 Saudi Arabia Dry Eye Syndrome Treatment Market
10.4.1 Saudi Arabia Dry Eye Syndrome Treatment Market by Type
10.4.2 Saudi Arabia Dry Eye Syndrome Treatment Market by Drug
10.4.3 Saudi Arabia Dry Eye Syndrome Treatment Market by Dosage
10.4.4 Saudi Arabia Dry Eye Syndrome Treatment Market by Distribution Channel
10.4.5 Saudi Arabia Dry Eye Syndrome Treatment Market by Sales Channel
10.4.6 Saudi Arabia Dry Eye Syndrome Treatment Market by Product
10.5 South Africa Dry Eye Syndrome Treatment Market
10.5.1 South Africa Dry Eye Syndrome Treatment Market by Type
10.5.2 South Africa Dry Eye Syndrome Treatment Market by Drug
10.5.3 South Africa Dry Eye Syndrome Treatment Market by Dosage
10.5.4 South Africa Dry Eye Syndrome Treatment Market by Distribution Channel
10.5.5 South Africa Dry Eye Syndrome Treatment Market by Sales Channel
10.5.6 South Africa Dry Eye Syndrome Treatment Market by Product
10.6 Nigeria Dry Eye Syndrome Treatment Market
10.6.1 Nigeria Dry Eye Syndrome Treatment Market by Type
10.6.2 Nigeria Dry Eye Syndrome Treatment Market by Drug
10.6.3 Nigeria Dry Eye Syndrome Treatment Market by Dosage
10.6.4 Nigeria Dry Eye Syndrome Treatment Market by Distribution Channel
10.6.5 Nigeria Dry Eye Syndrome Treatment Market by Sales Channel
10.6.6 Nigeria Dry Eye Syndrome Treatment Market by Product
10.7 Rest of LAMEA Dry Eye Syndrome Treatment Market
10.7.1 Rest of LAMEA Dry Eye Syndrome Treatment Market by Type
10.7.2 Rest of LAMEA Dry Eye Syndrome Treatment Market by Drug
10.7.3 Rest of LAMEA Dry Eye Syndrome Treatment Market by Dosage
10.7.4 Rest of LAMEA Dry Eye Syndrome Treatment Market by Distribution Channel
10.7.5 Rest of LAMEA Dry Eye Syndrome Treatment Market by Sales Channel
10.7.6 Rest of LAMEA Dry Eye Syndrome Treatment Market by Product
Chapter 11. Company Profiles
11.1 Johnson & Johnson (Johnson & Johnson Services, Inc.)
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental &Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Product Launches and Product Expansions:
11.1.5.2 Approvals and Trials:
11.1.6 SWOT Analysis
11.2 AbbVie, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.3 Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Product Launches and Product Expansions:
11.4 Novartis AG
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Sun Pharmaceuticals Industries Ltd
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Regional Analysis
11.5.4 Research & Development Expenses
11.5.5 Recent strategies and developments:
11.5.5.1 Product Launches and Product Expansions:
11.5.5.2 Approvals and Trials:
11.6 AFT Pharmaceuticals
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Product Launches and Product Expansions:
11.7 Santen Pharmaceutical Co., Ltd.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Regional Analysis
11.7.4 Research & Development Expenses
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.5.2 Approvals and Trials:
11.8 Oyster Point Pharma, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Research & Development Expenses
11.8.4 Recent strategies and developments:
11.8.4.1 Partnerships, Collaborations, and Agreements:
11.8.4.2 Approvals and Trials:
11.9 OASIS Medical, Inc.
11.9.1 Company Overview
11.9.2 Recent strategies and developments:
11.9.2.1 Product Launches and Product Expansions:
11.10. Otsuka Pharmaceutical Co., Ltd.
11.10.1 Company Overview

Companies Mentioned

  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • AbbVie, Inc.
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Novartis AG
  • Sun Pharmaceuticals Industries Ltd.
  • AFT Pharmaceuticals
  • Santen Pharmaceutical Co., Ltd.
  • Oyster Point Pharma, Inc.
  • OASIS Medical, Inc.
  • Otsuka Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Dry Eye Syndrome Treatment Market By Drug, By Dosage form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Dry Eye Syndrome Treatment Market By Drug, By Dosage form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 235 Pages
  • Global
From
Dry Eye Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Dry Eye Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 314 Pages
  • Global
2024 Global Forecast for Dry Eye Syndrome Treatment (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Dry Eye Syndrome Treatment (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Global Dry Eye Syndrome Market Analysis & Forecast to 2023-2033: Market By Type; By Product; By Drug; By Dosage; By Distribution Channel; and By Region - Product Image

Global Dry Eye Syndrome Market Analysis & Forecast to 2023-2033: Market By Type; By Product; By Drug; By Dosage; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032 - Product Image

Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.